In some solid tumors, pharmacological inhibition of CDK4/6 has demonstrated substantial effectiveness, mostly by preventing Rb phosphorylation and causing G1 cell cycle arrest in tumor cells [7]. This evidence concerns the gene RB1 and neoplasm.